Extending the utility of gene profiling data by bridging microarray platforms

Por Ferl, Gregory Z., Timmerman, John M., Witte, Owen N.
Publicado em 2003

ANTIBODY-CYTOKINE FUSION PROTEINS FOR TREATMENT OF CANCER: ENGINEERING CYTOKINES FOR IMPROVED EFFICACY AND SAFETY

Por Young, Patricia A., Morrison, Sherie L., Timmerman, John M.
Publicado no Semin Oncol (2014)

Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma

Por Xuan, Caiyun, Steward, Kristopher K., Timmerman, John M., Morrison, Sherie L.
Publicado em 2010

Maleimide conjugation markedly enhances the immunogenicity of both human and murine idiotype-KLH vaccines

Por Kafi, Kamran, Betting, David J., Yamada, Reiko E., Bacica, Michael, Steward, Kristopher K., Timmerman, John M.
Publicado em 2008

Targeted immunotherapy using anti-CD138-interferon α fusion proteins and bortezomib results in synergistic protection against multiple myeloma

Por Vasuthasawat, Alex, Yoo, Esther M., Trinh, Kham R., Lichtenstein, Alan, Timmerman, John M., Morrison, Sherie L.
Publicado no MAbs (2016)

Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo

Por Franki, Suzanne N., Steward, Kristopher K., Betting, David J., Kafi, Kamran, Yamada, Reiko E., Timmerman, John M.
Publicado em 2008

Generation of CD8(+) T cell–mediated immunity against idiotype-negative lymphoma escapees

Por Varghese, Bindu, Widman, Adam, Do, James, Taidi, Behnaz, Czerwinski, Debra K., Timmerman, John, Levy, Shoshana, Levy, Ronald
Publicado em 2009

Anti-CD20-interferon-β fusion protein therapy of murine B cell lymphomas

Por Trinh, K. Ryan, Vasuthasawat, Alex, Steward, Kristopher K., Yamada, Reiko E., Timmerman, John M., Morrison, Sherie L.
Publicado em 2013

Antibody-CD20-interferon-alpha fusion protein has superior in vivo activity against human B cell lymphomas compared to Rituximab, and enhanced complement-dependent cytotoxicity in...

Por Yamada, Reiko, Steward, Kristopher, Ngarmchamnanrith, Gataree, Trinh, Ryan, Khare, Sanjay, Sachdev, Raj, Grewal, Iqbal, Morrison, Sherie, Timmerman, John
Publicado em 2013

Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cells()

Por Betting, David J., Mu, Xi Y., Kafi, Kamran, McDonnel, Desmond, Rosas, Francisco, Gold, Daniel P., Timmerman, John M.
Publicado em 2009

Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma

Por Timmerman, John M., Vose, Julie M., Czerwinski, Debra K., Weng, Wen-Kai, Ingolia, Diane, Mayo, Martha, Denney, Dan W., Levy, Ronald
Publicado em 2009

A Phase I Dose-Finding Trial of Recombinant Interleukin-21 and Rituximab in Relapsed and Refractory Low Grade B-cell Lymphoproliferative Disorders

Por Timmerman, John M., Byrd, John C., Andorsky, David J., Yamada, Reiko E., Kramer, Janet, Muthusamy, Natarajan, Hunder, Naomi, Pagel, John M.
Publicado no Clin Cancer Res (2012)

Recombinant anti-CD20 antibody fragments for microPET imaging of B-cell lymphoma

Por Olafsen, Tove, Betting, David, Kenanova, Vania E., Salazar, Felix B., Clarke, Pat, Said, Jonathan, Raubitschek, Andrew A., Timmerman, John M., Wu, Anna M.
Publicado em 2009

Suppression of Fcγ-Receptor-Mediated Antibody Effector Function during Persistent Viral Infection

Por Yamada, Douglas H., Elsaesser, Heidi, Lux, Anja, Timmerman, John M., Morrison, Sherie L., de la Torre, Juan Carlos, Nimmerjahn, Falk, Brooks, David G.
Publicado no Immunity (2015)

ImmunoPET imaging of B-cell lymphoma using (124)I-anti-CD20 scFv dimers (diabodies)

Por Olafsen, Tove, Sirk, Shannon J., Betting, David J., Kenanova, Vania E., Bauer, Karl B., Ladno, Waldemar, Raubitschek, Andrew A., Timmerman, John M., Wu, Anna M.
Publicado em 2010

High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells

Por Myklebust, June H., Irish, Jonathan M., Brody, Joshua, Czerwinski, Debra K., Houot, Roch, Kohrt, Holbrook E., Timmerman, John, Said, Jonathan, Green, Michael R., Delabie, Jan, Kolstad, Arne, Alizadeh, Ash A., Levy, Ronald
Publicado em 2013

Phase I Study of Ipilimumab (MDX-010), an anti-CTLA-4 monoclonal antibody, in patients with Relapsed and Refractory B-cell non-Hodgkin Lymphoma

Por Ansell, Stephen M., Hurvitz, Sara A., Koenig, Patricia A., LaPlant, Betsy R., Kabat, Brian F., Fernando, Donna, Habermann, Thomas M., Inwards, David J., Verma, Meena, Yamada, Reiko, Erlichman, Charles, Lowy, Israel, Timmerman, John M.
Publicado em 2009

A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors

Por de Vos, Sven, Forero-Torres, Andres, Ansell, Stephen M, Kahl, Brad, Cheson, Bruce D, Bartlett, Nancy L, Furman, Richard R, Winter, Jane N, Kaplan, Henry, Timmerman, John, Whiting, Nancy C, Drachman, Jonathan G, Advani, Ranjana
Publicado em 2014

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

Por Ansell, Stephen M., Lesokhin, Alexander M., Borrello, Ivan, Halwani, Ahmad, Scott, Emma C., Gutierrez, Martin, Schuster, Stephen J., Millenson, Michael M., Cattry, Deepika, Freeman, Gordon J., Rodig, Scott J., Chapuy, Bjoern, Ligon, Azra H., Zhu, Lili, Grosso, Joseph F., Kim, Su Young, Timmerman, John M., Shipp, Margaret A., Armand, Philippe
Publicado no N Engl J Med (2014)

Analysis of Fcγ Receptor IIIa and IIa Polymorphisms: Lack of Correlation with Outcome in Trastuzumab-Treated Breast Cancer Patients

Por Hurvitz, Sara A., Betting, David J., Stern, Howard M., Quinaux, Emmanuel, Stinson, Jeremy, Seshagiri, Somasekar, Zhao, Ying, Buyse, Marc, Mackey, John, Driga, Adrian, Damaraju, Sambasivarao, Sliwkowski, Mark X., Robert, Nicholas J., Valero, Vicente, Crown, John, Falkson, Carla, Brufsky, Adam, Pienkowski, Tadeusz, Eiermann, Wolfgang, Martin, Miguel, Bee, Valerie, Marathe, Omkar, Slamon, Dennis J., Timmerman, John M.
Publicado em 2012